U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
187441187441Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)CompletedNo Results AvailablePreterm Birth|Pregnancy|MultifetalDrug: 17 alpha-hydroxyprogesterone caproate (17P)https://ClinicalTrials.gov/show/NCT00099164
187442187442CALERIE (PBRC, Baton Rouge) - Comprehensive Assessment of Long-Term Effects of Reducing Intake of EnergyCompletedNo Results AvailableAging|Cardiovascular Disease|Diabetes MellitusBehavioral: Caloric Restriction (CR)|Behavioral: Exercisehttps://ClinicalTrials.gov/show/NCT00099151
187443187443CALERIE (Washington University): Comprehensive Assessment of Long-term Effects of Reducing Intake of EnergyCompletedNo Results AvailableAgingBehavioral: Caloric Restriction (CR)|Behavioral: Exercisehttps://ClinicalTrials.gov/show/NCT00099138
187444187444Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: irinotecan hydrochloride|Drug: temozolomide|Procedure: adjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00099125
187445187445Effect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin of Healthy Adults With Fitzpatrick Skin Type IICompletedNo Results AvailableNon-melanomatous Skin Cancer|Precancerous ConditionGenetic: microarray analysis|Procedure: biopsy|Procedure: evaluation of cancer risk factorshttps://ClinicalTrials.gov/show/NCT00099112
187446187446CALERIE (Tufts) - Comprehensive Assessment of Long-term Effects of Reducing Intake of EnergyCompletedNo Results AvailableAgingBehavioral: Caloric Restriction (CR)https://ClinicalTrials.gov/show/NCT00099099
187447187447Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate CancerActive, not recruitingNo Results AvailableProstate CancerDrug: bicalutamide|Drug: docetaxel|Drug: goserelin acetate|Drug: leuprolide acetate|Procedure: adjuvant therapy|Procedure: neoadjuvant therapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00099086
187448187448Lapatinib in Treating Patients With Recurrent Glioblastoma MultiformeCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: lapatinib ditosylatehttps://ClinicalTrials.gov/show/NCT00099060
187449187449Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering MyelomaCompletedHas ResultsMonoclonal Gammopathy of Undetermined Significance|Multiple Myeloma|Smoldering Multiple MyelomaDrug: celecoxib|Drug: placebo|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00099047
187450187450Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral LeukoplakiaCompletedHas ResultsHead and Neck Cancer|Oral LeukoplakiaDrug: pioglitazone hydrochloridehttps://ClinicalTrials.gov/show/NCT00099021
187451187451Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal WomenCompletedNo Results AvailableBreast Cancer|Endometrial CancerDietary Supplement: Genistein|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT00099008
187452187452Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerCompletedNo Results AvailableCervical CancerDrug: cisplatin|Drug: tirapazamine|Radiation: brachytherapy|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00098995
187453187453Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNo Results AvailableColorectal CancerDrug: bortezomib|Drug: fluorouracil|Drug: leucovorin calcium|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00098982
187454187454UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy ParticipantsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: resveratrolhttps://ClinicalTrials.gov/show/NCT00098969
1874551874557-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung CancerCompletedHas ResultsExtensive Stage Small Cell Lung Cancer|Recurrent Small Cell Lung CancerDrug: topotecan hydrochloride|Drug: 7-hydroxystaurosporinehttps://ClinicalTrials.gov/show/NCT00098956
187456187456NGR-TNF in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableColorectal Cancer|Head and Neck Cancer|Kidney Cancer|Unspecified Adult Solid Tumor, Protocol SpecificBiological: CNGRC peptide-TNF alpha conjugatehttps://ClinicalTrials.gov/show/NCT00098943
187457187457Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung CancerTerminatedNo Results AvailableLung CancerDrug: autologous tumor cell vaccine|Drug: therapeutic autologous dendritic cells|Procedure: adjuvant therapy|Procedure: biological therapy|Procedure: conventional surgery|Procedure: surgery|Procedure: tumor cell derivative vaccine|Procedure: vaccine therapyhttps://ClinicalTrials.gov/show/NCT00098917
187458187458MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or LymphomasCompletedNo Results AvailableAdult Grade III Lymphomatoid Granulomatosis|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Primary CeDrug: entinostat|Drug: isotretinoinhttps://ClinicalTrials.gov/show/NCT00098891
187459187459Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity CancerDrug: carboplatinhttps://ClinicalTrials.gov/show/NCT00098878
187460187460Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or NeuroblastomaCompletedHas ResultsCentral Nervous System Tumor, Pediatric|NeuroblastomaDrug: temozolomide|Drug: thalidomidehttps://ClinicalTrials.gov/show/NCT00098865
187461187461Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid CancerActive, not recruitingNo Results AvailableHead and Neck CancerDrug: rosiglitazone maleatehttps://ClinicalTrials.gov/show/NCT00098852
187462187462Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)Active, not recruitingHas ResultsRecurrent Childhood Acute Lymphoblastic LeukemiaDrug: L-asparaginase|Drug: doxorubicin hydrochloride|Drug: therapeutic hydrocortisone|Drug: vincristine sulfate|Biological: epratuzumab|Drug: cytarabine|Drug: prednisone|Drug: pegaspargase|Drug: dexrazoxane hydrochloride|Drug: methotrexate|Drug: etoposide|Drug: cyclophosphamide|Drug: leucovorin calcium|Biological: filgrastimhttps://ClinicalTrials.gov/show/NCT00098839
187463187463SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic SyndromesCompletedNo Results AvailableAcute Undifferentiated Leukemia|Adult Acute Megakaryoblastic Leukemia (M7)|Adult Acute Minimally Differentiated Myeloid Leukemia (M0)|Adult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With MaturaDrug: ispinesib|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00098826
187464187464Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive IodineCompletedHas ResultsRecurrent Thyroid Cancer|Stage IV Follicular Thyroid Cancer|Stage IV Papillary Thyroid CancerDrug: romidepsin|Other: laboratory biomarker analysis|Procedure: positron emission tomographyhttps://ClinicalTrials.gov/show/NCT00098813
187465187465Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the OvariesCompletedNo Results Availablebrca1 Mutation Carrier|brca2 Mutation Carrier|Ovarian CancerDrug: fenretinidehttps://ClinicalTrials.gov/show/NCT00098800
187466187466Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal CancerActive, not recruitingHas ResultsColorectal CancerBiological: bevacizumab|Drug: fluorouracil|Drug: irinotecan hydrochloride|Drug: leucovorin calcium|Drug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT00098787
187467187467Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS LymphomaCompletedHas ResultsLymphomaBiological: filgrastim|Biological: rituximab|Drug: cytarabine|Drug: etoposide|Drug: leucovorin calcium|Drug: methotrexate|Drug: temozolomidehttps://ClinicalTrials.gov/show/NCT00098774
187468187468VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain TumorsCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: laromustinehttps://ClinicalTrials.gov/show/NCT00098761
187469187469Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected SubjectsCompletedHas ResultsHIV InfectionsDrug: Optimized Background Therapy (OBT)|Drug: maraviroc (UK-427,857)|Drug: Optimized Background Therapy (OBT)|Drug: maraviroc (UK-427,857)|Drug: Optimized Background Therapy (OBT)https://ClinicalTrials.gov/show/NCT00098748
187470187470Efficacy and Safety of FTY720 in Patients Who Receive a Kidney TransplantationCompletedNo Results AvailableKidney TransplantationDrug: FTY720https://ClinicalTrials.gov/show/NCT00098735

* Görseller ve İçerik tekif hakkına sahip olabilir